Patients with CLE who have specific patient characteristics may have lower treatment response than patients who do not have these characteristics.

More than 50% of patients with systemic lupus erythematosus (SLE) develop lupus nephritis (LN) during the disease, which may ...

Royalty Pharma has signed a deal to pay Biogen $250m to support the development of its late-stage experimental lupus ...

Objective At least half of patients with systemic lupus erythematosus (SLE) develop organ damage as a consequence of autoimmune disease or long-term therapeutic steroid use. This study synthesised ...

National Library of Medicine. Systemic lupus erythematosus. Lupus Foundation of America. Complementary and alternative medicine for lupus. Centers for Disease Control and Prevention. Symptoms of lupus ...

GATHER1 and GATHER2 data indicate that ACP could slow the growth of GA lesions while maintaining a favourable safety profile. Its sustained efficacy was evident for more than a two-year follow-up ...

Objective Hypertension (HTN) is common in systemic lupus erythematosus (SLE), representing a key risk factor for cardiovascular and renal disease. We described HTN treatment patterns in SLE, evaluated ...

Diagnosis of systemic lupus erythematosus meeting the 2019 European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) SLE classification criteria at least 6 months prior to ...

SLE-associated CNS vasculitis was favored because ... small perforating arteries are most commonly affected and the ischemic lesions are localized in the deep or subcortical white matter and ...

Methods Four databases were systematically searched, and a Bayesian hierarchical linear mixed model was constructed to estimate the global, regional, and country-specific incidence and prevalence of ...

In SLE, alternative anti-CD20 antibodies may be more consistently effective ... 19 These long-term data showed a more consistent major response in lupus erythematosus non-specific lesions and oral ...

aCentre for Rheumatology Research, Department of Medicine, University College London, Rayne Building, London W1CE 6JF, UK bCentre for Adolescent Rheumatology Versus Arthritis, Department of Medicine, ...